HopeStage
Back to all studies
RecruitingNCT05573074

Near-infrared light or sham and brain blood flow in depression

About this titleRead the official source — NCT05573074
Device studyAges 18–65United States
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Listed locations
Boston and 2 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 1, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
120
Sponsor
NYU Langone Health
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT05573074
Official title
Show the full official title

Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33

Recruitment & locations

Currently recruiting

Boston · New York · Orangeburg

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is NYU Langone Health.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies